These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 966635)

  • 21. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
    Butler GE; Sellar RE; Walker RF; Hendry M; Kelnar CJ; Wu FC
    J Clin Endocrinol Metab; 1992 Jul; 75(1):37-44. PubMed ID: 1619029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral conversion and uptake of androgens in a XXY-man with Klinefelter's syndrome.
    Sulcová J; Jirásek JE; Neuwirth J; Raboch J; Stárka L
    Endokrinologie; 1978 Nov; 72(3):304-10. PubMed ID: 744177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on intestinal lymphatic absorption of drugs. I. Lymphatic absorption of alkyl ester derivatives and alpha-monoglyceride derivatives of drugs.
    Sugihara J; Furuuchi S; Nakano K; Harigaya S
    J Pharmacobiodyn; 1988 May; 11(5):369-76. PubMed ID: 3171878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain cell nuclear retention of testosterone metabolites, 5alpha-dihydrotestosterone and estradiol-17beta, in adult rats.
    Lieberburg I; McEwen BS
    Endocrinology; 1977 Feb; 100(2):588-97. PubMed ID: 832638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals.
    Meriggiola MC; Armillotta F; Costantino A; Altieri P; Saad F; Kalhorn T; Perrone AM; Ghi T; Pelusi C; Pelusi G
    J Sex Med; 2008 Oct; 5(10):2442-53. PubMed ID: 18624972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.
    Schnabel PG; Bagchus W; Lass H; Thomsen T; Geurts TB
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):579-85. PubMed ID: 17371478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
    du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
    J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides.
    Giagulli VA; Verdonck L; Deslypere JP; Giorgino R; Vermeulen A
    J Clin Endocrinol Metab; 1993 Feb; 76(2):429-31. PubMed ID: 8432786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone.
    Täuber U; Schröder K; Düsterberg B; Matthes H
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):145-9. PubMed ID: 3770015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine b-Hydroxylase: Determination of half-life and appearance in lymph fluid after IV injection of 125 I-DBH into rats.
    Geyer SJ; Schanberg SM
    Life Sci; 1982 Mar; 30(13):1087-100. PubMed ID: 7078347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the metabolism of testosterone trans-4-n-butylcyclohexanoic acid in the cynomolgus monkey, Macaca fascicularis.
    Monder C; Marshall DE; Laughlin LS; Blye RP
    J Steroid Biochem Mol Biol; 1994 Sep; 50(5-6):305-11. PubMed ID: 7918117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.
    Meuleman EJ; Legros JJ; Bouloux PM; Johnson-Levonas AO; Kaspers MJ; Elbers JM; Geurts TB; Meehan AG;
    Aging Male; 2015; 18(3):157-63. PubMed ID: 26030346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism.
    Minnemann T; Schubert M; Freude S; Hübler D; Gouni-Berthold I; Schumann C; Christoph A; Oettel M; Ernst M; Mellinger U; Krone W; Jockenhövel F
    J Endocrinol Invest; 2008 Aug; 31(8):718-23. PubMed ID: 18852533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S; Swyer GI; Lawrence DM
    Acta Eur Fertil; 1977 Dec; 8(4):297-9. PubMed ID: 610314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.
    Nieschlag E; Mauss J; Coert A; Kićović P
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):366-74. PubMed ID: 1173495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic absorption of hypolipidemic compound, 1-O-[p-(myristyloxy)-alpha-methylcinnamoyl] glycerol (LK-903).
    Sugihara J; Furuuchi S
    J Pharmacobiodyn; 1988 Feb; 11(2):121-30. PubMed ID: 3379564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.